PMA device
Therapy Ablation Catheter (4mm and 8mm)
Irvine Biomedical, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Nov 13, 2006, newest Dec 16, 2022Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
33,251
Naming "Therapy"
MAUDE reports
3,646
Brand "Therapy", since 2015
PubMed studies
2,820,666
Mentioning "Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Therapy Ablation Catheter (4mm and 8mm)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- Therapy Ablation Catheter (4mm and 8mm), Electrophysiology Cables (16, 17, 18 and 19 Series)PMA supplement
P040014-S047 · Decided Dec 16, 2022 · 49 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- Therapy Ablation Catheter (4mm and 8mm), Electrophysiology Cables (16, 17, 18 and 19 Series)PMA supplement
P040014-S046 · Decided Nov 15, 2022 · 27 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- Therapy Ablation CathetersPMA supplement
P040014-S040 · Decided Nov 2, 2020 · 112 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
3 more FDA decisions with a free account
Older decisions: P040014-S008, P040014-S004, P040014-S003
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy System (WiSE CRT)National analysisReview closedCAG-00471NUpdated Nov 18, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Transcatheter Infusion TherapyLocal determinationIn effectL34084CGS Administrators, LLCUpdated Aug 28, 2026
- Cardiac Resynchronization Therapy (CRT)Local determinationIn effectL39080Palmetto GBAUpdated Oct 19, 2021
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Artificial Hearts and related devices, including Ventricular Assist Devices for Bridge-to-Transplant and Destination TherapyNational analysisReview closedCAG-00453NUpdated Nov 19, 2026
- Aprepitant for Chemotherapy-Induced EmesisNational analysisReview closedCAG-00248RUpdated Nov 19, 2026
- Anticancer Chemotherapy for Colorectal CancerNational analysisReview closedCAG-00179NUpdated Nov 19, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Therapy", any status and sponsor, newest update first.
The Methodist Hospital Research InstituteAcademic, hospital or other
NCT07948330 · 23 participants (planned) · Start Sep 16, 2026 · Primary completion Oct 1, 2027
Device: Magstim - rTMS system · For: Urinary Incontinence; Prostate Treatment; Incontinence After Prostate Treatment
Sites: Houston, Texas
- Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart FailurePivotal-lookingRecruiting
CVRx, Inc.Not on our public-company list
NCT07232030 · 2,500 participants (planned) · Start Apr 24, 2026 · Primary completion Jan 2033
Device: Barostim System · For: Heart Failure; Heart Failure NYHA Class II; Heart Failure NYHA Class III
Sites: Mobile, Alabama; Los Angeles, California; Clearwater, Florida · 26 sites in all
- Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast CancerNot yet recruiting
Galzu Institute of Research, Teaching, Science and Applied TechnologyAcademic, hospital or other
NCT06045572 · 120 participants (planned) · Start May 1, 2027 · Primary completion May 1, 2027
Device: VTM examination and breast biopsy · For: Breast Cancer Female
33,248 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Therapy", and for the whole product code for context.
This brand
3,646 reports: 1,783 malfunction, 1,750 injury, 68 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
Shenzhen Dongdixin Technology Co., Ltd.
3005170249-2026-00007 · Received Oct 30, 2026
Device type: Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Burn(s)
- TD2 Therapy DiscInjury
3006630150-2026-08273 · Received Oct 29, 2026 · Event dated Sep 14, 2026
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF)
Device problem as coded: Failure to Charge; Failure to Power Up; Unexpected Therapeutic Results; Charging Problem; Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pain
- TD2 Therapy DiscInjury
3006630150-2026-08070 · Received Oct 26, 2026 · Event dated Oct 5, 2026
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF)
Device problem as coded: Unexpected Therapeutic Results; Connection Problem
Patient problem as coded: Pain
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3255-2011 · Started Feb 10, 2011 · Posted by FDA Sep 16, 2011
Reason given: The recall was initiated because St. Jude Medical has confirmed that the Therapy Ablation Catheter, 4 mm Tip Thermistor Quadripolar, were packaged with the incorrect Instructions for Use (IFU). To ensure accuracy of device labeling, St. Jude Medical is requesting that the incorrect IFU be replaced with the enclose,...
Cause as FDA categorized it: Process control · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-3256-2011 · Started Feb 10, 2011 · Posted by FDA Sep 16, 2011
Reason given: The recall was initiated because St. Jude Medical has confirmed that the Therapy Ablation Catheter, 4 mm Tip Thermistor Quadripolar, were packaged with the incorrect Instructions for Use (IFU). To ensure accuracy of device labeling, St. Jude Medical is requesting that the incorrect IFU be replaced with the enclose,...
Cause as FDA categorized it: Process control · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-3257-2011 · Started Feb 10, 2011 · Posted by FDA Sep 16, 2011
Reason given: The recall was initiated because St. Jude Medical has confirmed that the Therapy Ablation Catheter, 4 mm Tip Thermistor Quadripolar, were packaged with the incorrect Instructions for Use (IFU). To ensure accuracy of device labeling, St. Jude Medical is requesting that the incorrect IFU be replaced with the enclose,...
Cause as FDA categorized it: Process control · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Published research
The most relevant PubMed records for "Therapy"[tiab]. The summary above synthesizes these.
- Therapy resistance and metastasis.
Sleeman JP · Clin Exp Metastasis · 2023Editorial, Research Support, Non-U.S. Gov't
- Guidelines for mono, double and triple antithrombotic therapy.
van Uden RCAE, Houtenbos I, Griffioen-Keijzer A, et al. · Postgrad Med J · 2021Review
- [Diuretics].
STREIFF F · Rev Med Nancy · 1961
- Outpatient bronchodilator therapy.
GANDEVIA B, HUME KM, PRIME FJ · Lancet · 1957
- [FRAMISONE].
Med Cir Farm · 1959
- AOTA's Societal Statement Denouncing Conversion "Therapy".
Am J Occup Ther · 2022
- Acne therapy.
HORNE SF · Med Times · 1961
- Shock therapy.
SLOANE P · J Albert Einstein Med Cent (Phila) · 1953
- Optimising dialytic therapy.
Rana DS, Gupta A · J Indian Med Assoc · 2001
- Current status of cancer starvation therapy.
Li J, Tong D, Lin J · Zhejiang Da Xue Xue Bao Yi Xue Ban · 2022Review
- Gene therapy clinical trials, where do we go? An overview.
Arabi F, Mansouri V, Ahmadbeigi N · Biomed Pharmacother · 2022Review
- Applications of Antimicrobial Photodynamic Therapy against Bacterial Biofilms.
Songca SP, Adjei Y · Int J Mol Sci · 2022Review
Other devices of this type
Also filed under product code LPB.
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
- Biosense Webster CablesBiosense Webster, Inc. · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.